Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 8/2012

01-08-2012 | Original Article

Compliance with fluoride custom trays in irradiated head and neck cancer patients

Authors: Juliette Thariat, Liliane Ramus, Vincent Darcourt, Pierre-Yves Marcy, N. Guevara, Guillaume Odin, Gilles Poissonnet, Laurent Castillo, Ali Mohammed Ali, Christian Righini

Published in: Supportive Care in Cancer | Issue 8/2012

Login to get access

Abstract

Purpose

The purpose of this study is to assess compliance with fluoride gel custom trays in irradiated head and neck cancer patients.

Methods and materials

One hundred fifty-five consecutive patients on remission following radiation therapy of head and neck cancers were assessed retrospectively for dental care practices prior to radiation and prospectively for long-term compliance with custom trays from November 2009 to January 2010. A five-item questionnaire was filled in by patients in the waiting room, and a 15-item questionnaire by the physician in charge during the corresponding follow-up visit.

Results

Ten percent of patients were edentulous at inclusion. Among dentate patients, 17% had total extractions. With a mean follow-up of 24 months, 19% of patients used custom trays for over a year. Primary stage, age, and tobacco consumption were correlated with compliance with custom trays. More than half of dentate patients developed carious lesions, and 8% had stage 1–3 osteoradionecrosis of the whole population of edentulous and dentate patients.

Conclusion

Compliance with custom trays was poor in this series. Specific postirradiation dental care follow-up visits and education have demonstrated their utility in the era of 2D irradiation. We currently advocate an 18-month compliance with custom trays in IMRT patients on the basis of the Parsport trial, after which we assess the quality of salivary recovery before recommending prolonged use or interruption. Data with innovative irradiation techniques are however required.
Literature
1.
Thariat J, De Mones E, Darcourt V, Poissonnet G, Dassonville O, Savoldelli C et al (2010) Teeth and irradiation in head and neck cancer. Cancer Radiother 14(2):128–136PubMedCrossRef
2.
DePaola LG, Peterson DE, Overholser CD Jr, Suzuki JB, Minah GE, Williams LT et al (1986) Dental care for patients receiving chemotherapy. J Am Dent Assoc 112(2):198–203PubMed
3.
Daly TE, Drane JB, MacComb WS (1972) Management of problems of the teeth and jaw in patients undergoing irradiation. Am J Surg 124(4):539–542PubMedCrossRef
4.
Horiot JC, Schraub S, Bone MC, Bain Y, Ramadier J, Chaplain G et al (1983) Dental preservation in patients irradiated for head and neck tumours: a 10-year experience with topical fluoride and a randomized trial between two fluoridation methods. Radiother Oncol 1(1):77–82PubMedCrossRef
5.
Jansma J, Vissink A, Bouma J, Vermey A, Panders AK, Gravenmade EJ (1992) A survey of prevention and treatment regimens for oral sequelae resulting from head and neck radiotherapy used in Dutch radiotherapy institutes. Int J Radiat Oncol Biol Phys 24(2):359–367PubMedCrossRef
6.
Shannon IL, Starcke EN, Wescott WB (1977) Effect of radiotherapy on whole saliva flow. J Dent Res 56(6):693PubMedCrossRef
7.
Thariat J, de Mones E, Darcourt V, Poissonnet G, Marcy PY, Guevara N et al (2010) Teeth and irradiation: dental care and treatment of osteoradionecrosis after irradiation in head and neck cancer. Cancer Radiother 14(2):137–144PubMedCrossRef
8.
Dreizen S, Daly TE, Drane JB, Brown LR (1977) Oral complications of cancer radiotherapy. Postgrad Med 61(2):85–92PubMed
9.
Silva AR, Alves FA, Berger SB, Giannini M, Goes MF, Lopes MA (2009) Radiation-related caries and early restoration failure in head and neck cancer patients. A polarized light microscopy and scanning electron microscopy study. Support Care Cancer 18(1):83–87CrossRef
10.
Dreizen S, Brown LR, Daly TE, Drane JB (1977) Prevention of xerostomia-related dental caries in irradiated cancer patients. J Dent Res 56(2):99–104PubMedCrossRef
11.
Fleming TJ (1990) Oral tissue changes of radiation-oncology and their management. Dent Clin North Am 34(2):223–237PubMed
12.
Horiot JC, Bone MC, Ibrahim E, Castro JR (1981) Systematic dental management in head and neck irradiation. Int J Radiat Oncol Biol Phys 7(8):1025–1029PubMedCrossRef
13.
Horiot JC, Malka G, Schraub S, Le Dorze C, Ramadier J, Martin P et al (1977) Prevention of caries and osteonecrosis through daily local fluoridation in radiotherapy patients. Rev Stomatol Chir Maxillofac 78(6):385–396PubMed
14.
Billings RJ, Meyerowitz C, Featherstone JD, Espeland MA, Fu J, Cooper LF et al (1988) Retention of topical fluoride in the mouths of xerostomic subjects. Caries Res 22(5):306–310PubMedCrossRef
15.
Shannon IL, Edmonds EJ (1978) Effect of fluoride concentration on rehardening of enamel by a saliva substitute. Int Dent J 28(4):421–426PubMed
16.
Epstein JB, van der Meij EH, Emerton SM, Le ND, Stevenson-Moore P (1995) Compliance with fluoride gel use in irradiated patients. Spec Care Dentist 15(6):218–222PubMedCrossRef
17.
Bransfield D, Horiot JC, Bone M (1987) High compliance with fluoride treatment by patients irradiated for head and neck tumors. A theoretical interpretation. J Psychosoc Oncol 4(3):43–51CrossRef
18.
Chambers MS, Mellberg JR, Keene HJ, Bouwsma OJ, Garden AS, Sipos T et al (2006) Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 1: fluorides. Oral Oncol 42(9):934–945PubMedCrossRef
19.
Chambers MS, Mellberg JR, Keene HJ, Bouwsma OJ, Garden AS, Sipos T et al (2006) Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 2: phase I study. Oral Oncol 42(9):946–953PubMedCrossRef
20.
Walker MP, Williams KB, Wichman B (2008) Post-radiation dental index: development and reliability. Support Care Cancer 16(5):525–530PubMedCrossRef
21.
Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C et al (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 12(2):127–136PubMedCrossRef
22.
Ben-David MA, Diamante M, Radawski JD, Vineberg KA, Stroup C, Murdoch-Kinch CA et al (2007) Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions. Int J Radiat Oncol Biol Phys 68(2):396–402PubMedCrossRef
23.
Studer G, Studer SP, Zwahlen RA, Huguenin P, Gratz KW, Lutolf UM et al (2006) Osteoradionecrosis of the mandible: minimized risk profile following intensity-modulated radiation therapy (IMRT). Strahlenther Onkol 182(5):283–288PubMedCrossRef
24.
Roing M, Hirsch JM, Holmstrom I (2006) Ways of understanding the encounter with head and neck cancer patients in the hospital dental team—a phenomenographic study. Support Care Cancer 14(10):1046–1054PubMedCrossRef
25.
Silverman S Jr, Rankin KV (2010) Oral and pharyngeal cancer control through continuing education. J Cancer Educ 25(3):277–278PubMedCrossRef
26.
Thariat J, Ramus L, Maingon P, Odin G, Gregoire V, Darcourt V et al (2011) Dentalmaps: automatic dental delineation for radiotherapy planning in head-and-neck cancer. Int J Radiat Oncol Biol Phys (in press)
Metadata
Title
Compliance with fluoride custom trays in irradiated head and neck cancer patients
Authors
Juliette Thariat
Liliane Ramus
Vincent Darcourt
Pierre-Yves Marcy
N. Guevara
Guillaume Odin
Gilles Poissonnet
Laurent Castillo
Ali Mohammed Ali
Christian Righini
Publication date
01-08-2012
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 8/2012
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1279-5

Other articles of this Issue 8/2012

Supportive Care in Cancer 8/2012 Go to the issue

Original Article

Challenging the perceptions of cancer service provision for the disadvantaged: evaluating utilisation of cancer support services in Western Australia

Original Article

Topical silver sulfadiazine for the prevention of acute dermatitis during irradiation for breast cancer

Original Article

Development of a knowledge assessment tool for dermatotoxicity caused by inhibitors of epidermal growth factor receptor

Original Article

Partner-assisted emotional disclosure for patients with GI cancer: 8-week follow-up and processes associated with change

Original Article

A randomized, double-blind, placebo-controlled trial of misoprostol for oral mucositis secondary to high-dose chemotherapy

Erratum

Erratum to: The nutritional risk in oncology: a study of 1,453 cancer outpatients
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits